RaySearch Laboratories AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	439.3	407.3	462.7	343.68	160.27	102.54
Cash & Short-Term Investments	439.3	407.3	462.7	343.68	160.27	102.54
Cash Growth	-12.73%	-11.97%	34.63%	114.44%	56.31%	-39.24%
Accounts Receivable	448.9	473.9	444.8	383.73	370.57	317.36
Other Receivables	72.2	19.9	23.3	30.07	27.7	40.81
Receivables	521.1	493.8	468.1	413.79	398.26	358.17
Inventory	49	22	10.6	9.32	14.09	29.99
Prepaid Expenses	-	16.6	17.1	12.36	37.47	20.13
Other Current Assets	-	31	26.2	23.29	17.83	5.55
Total Current Assets	1,009	970.7	984.7	802.45	627.92	516.37
Property, Plant & Equipment	430.3	447.3	526.7	590.42	649.07	666.54
Other Intangible Assets	576.5	558.7	548.2	530.46	518.66	523.11
Long-Term Accounts Receivable	-	0.9	20.9	22.2	54.33	10
Long-Term Deferred Tax Assets	8.4	8.4	3.9	5.73	25.6	28.53
Other Long-Term Assets	3	6	6.8	1.43	0.36	0.21
Total Assets	2,028	1,992	2,091	1,953	1,876	1,745
Accounts Payable	26.9	35.4	38.8	42.09	24.03	48.77
Accrued Expenses	-	65.2	57.5	41.72	50.71	44.9
Current Portion of Long-Term Debt	-	-	-	-	-	21.27
Current Portion of Leases	78.5	77.5	77.1	97.38	81.31	49.11
Current Income Taxes Payable	-	15.5	42.2	5.49	4.98	3.71
Current Unearned Revenue	358.3	355.9	454.2	461.14	460.71	341.01
Other Current Liabilities	99.5	20.4	34	27.24	15.36	7.98
Total Current Liabilities	563.2	569.9	703.8	675.05	637.1	516.75
Long-Term Leases	298.8	317.3	394.9	431.98	474.08	491.02
Long-Term Deferred Tax Liabilities	121.9	118.6	114.9	109.53	106.87	107.78
Other Long-Term Liabilities	1	0.9	0.9	0.88	0.74	0.88
Total Liabilities	984.9	1,007	1,215	1,217	1,219	1,116
Common Stock	1,043	17.1	17.1	17.14	17.14	17.14
Additional Paid-In Capital	-	2	2	1.98	1.98	1.98
Retained Earnings	-	982	856.9	721.98	640.41	616.63
Comprehensive Income & Other	-	-15.8	0.7	-5.87	-2.37	-7.44
Shareholders' Equity	1,043	985.3	876.7	735.23	657.16	628.31
Total Liabilities & Equity	2,028	1,992	2,091	1,953	1,876	1,745
Total Debt	377.3	394.8	472	529.36	555.39	561.4
Net Cash (Debt)	62	12.5	-9.3	-185.68	-395.12	-458.86
Net Cash Growth	14.95%	-	-	-	-	-
Net Cash Per Share	1.81	0.36	-0.27	-5.42	-11.53	-13.38
Filing Date Shares Outstanding	34.28	34.28	34.28	34.28	34.28	34.28
Total Common Shares Outstanding	34.28	34.28	34.28	34.28	34.28	34.28
Working Capital	446.2	400.8	280.9	127.4	-9.18	-0.39
Book Value Per Share	30.41	28.74	25.57	21.45	19.17	18.33
Tangible Book Value	466.2	426.6	328.5	204.78	138.49	105.2
Tangible Book Value Per Share	13.60	12.44	9.58	5.97	4.04	3.07
Machinery	-	281.5	284.7	262.43	243.37	224.37
Order Backlog	-	1,528	1,813	1,864	1,940	1,363